In vitro radiosensitivity of primary human fibroblasts. Lack of correlation with acute radiation toxicity in patients with head and neck cancer

Radiotherapy and Oncology

Volumn 43, Issue 2, 1997, Pages 181-188

  Rudat, Volker ^a   Dietz, Andreas ^a   Conradt, Christian ^a   Weber, Klaus Josef ^a   Flentje, Michael ^b  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

Fibroblast radiosensitivity; Normal tissue response; Predictive assay; Radiotherapy

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; CELL SURVIVAL; CLINICAL PROTOCOL; CLINICAL TRIAL; CLONOGENIC ASSAY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FIBROBLAST; HEAD AND NECK CANCER; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PREDICTION; PRIORITY JOURNAL; RADIATION DOSE; RADIATION RESPONSE; RADIATION SICKNESS; RADIOSENSITIVITY; STATISTICAL ANALYSIS;

ACUTE DISEASE; ADULT; AGED; CELL SURVIVAL; FEMALE; FIBROBLASTS; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RADIATION INJURIES; RADIATION TOLERANCE; RADIOTHERAPY; REPRODUCIBILITY OF RESULTS;

EID: 0030909892     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-8140(97)01933-6     Document Type: Article

References (20)

1. Arlett, C.F., Green, M.H.L., Priestley, A., Harcourt, S.A. and Mayne, L.V. Comparative human cellular radiosensitivity: I. The effect of SV40 transformation and immortalization on the gamma-irradiation survival of skin derived fibroblasts from normal individuals and from ataxia-telangiectasia patients and heterozygotes. Int. J. Radiat. Biol. 54: 911-928, 1988.
2. Begg, A.C., Russell, N.S., Knaken, H. and Lebesque, J.V. Lack of correlation of human fibroblast radiosensitivity in vitro with early skin reactions in patients undergoing radiotherapy. Int. J. Radiat. Biol. 64: 393-405, 1993.
3. Bentzen, S.M., Overgaard, M. and Overgaard, J. Clinical correlations between late normal tissue endpoints after radiotherapy: implications for predictive assays of radiosensitivity. Eur. J. Cancer 29A: 1373-1376, 1993.
4. Bland, J.M. and Altman, D.G. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1: 307-310, 1986.
5. Brock, W.A., Tucker, S.L., Geara, F.B., Turesson, I., Wike, J., Nyman, J. and Peters, L.J. Fibroblast radiosensitivity versus acute and late normal skin responses in patients treated for breast cancer. Int. J. Radiat. Oncol. Biol. Phys. 32: 1371-1379, 1995.
6. Burnet, N.G., Nyman, J., Turesson, I., Wurm, R., Yarnold, J.R. and Peacock, J.H. Prediction of normal-tissue tolerance to radiotherapy from in-vitro cellular radiation sensitivity. Lancet 339: 1570-1571, 1992.
7. Burnet, N.G., Nyman, J., Turesson, I., Wurm, R., Yarnold, J.R. and Peacock, J.H. The relationship between cellular radiation sensitivity and tissue response may provide the basis for individualising radiotherapy schedules. Radiother. Oncol. 33: 228-238, 1994.
8. Deschavanne, P.J., Debieu, D., Fertil, B. and Malaise, E.P. Re-evaluation of in vitro radiosensitivity of human fibroblasts of different genetic origins [published erratum appears in Int. J. Radiat. Biol. 50(6): 1129, 1986]. Int. J. Radiat. Biol. Relat. Stud. Phys. Chem. Med. 50: 279-293, 1986.
9. Geara, F.B., Peters, L.J., Ang, K.K., Wike, J.L. and Brock, W.A. Prospective comparison of in vitro normal cell radiosensitivity and normal tissue reactions in radiotherapy patients. Int. J. Radiat. Oncol. Biol. Phys. 27: 1173-1179, 1993.
10. Johansen, J., Bentzen, S.M., Overgaard, J. and Overgaard, M. Evidence for a positive correlation between in vitro radiosensitivity of normal human skin fibroblasts and the occurrence of subcutaneous fibrosis after radiotherapy. Int. J. Radiat. Biol. 66: 407-412, 1994.
11. Johansen, J., Bentzen, S.M. and Overgaard, M. Relationship between the in vitro radiosensitivity of skin fibroblasts and the expression of subcutaneous fibrosis, telangiectasia, and skin erythema after radiotherapy. Radiother. Oncol. 40: 101-109, 1996.
12. Norman, A., Kagan, A.R. and Chan, S.L. The importance of genetics for the optimization of radiation therapy. A hypothesis. Am. J. Clin. Oncol. 11: 84-88, 1988.
13. Suit, H.D., Baumann, M., Skates, S. and Convery, K. Clinical interest in determinations of cellular radiation sensitivity. Int. J. Radiat. Biol. 56: 725-737, 1989.
14. Swift, M., Morrell, D., Massey, R.B. and Chase, C.L. Incidence of cancer in 161 families affected by ataxia-telangiectasia [see comments]. N. Engl. J. Med. 325: 1831-1836, 1991.
15. Swift, M., Reitnauer, P.J., Morrell, D. and Chase, C.L. Breast and other cancers in families with ataxia-telangiectasia. N. Engl. J. Med. 316: 1289-1294, 1987.
16. Taylor, A.M.R., Harnden, D.G., Arlett, C.F., Harcourt, S.A., Lehmann, A.R., Stevens, S. and Bridges, B.A. Ataxia telangiectasia: a human mutation with abnormal radiation sensitivity. Nature 258: 427-429, 1975.
17. Taylor, J. Calculating the mean inactivation dose [letter]. Radiat. Res. 108: 112, 1986.
18. Tucker, S.L., Geara, F.B., Peters, L.J. and Brock, W.A. How much could radiotherapy dose be altered for individual patients based on a predictive assay of normal-tissue radiosensitivity? Radiother. Oncol. 38: 103-113, 1996.
19. Tucker, S.L., Turesson, I. and Thames, H.D. Evidence for individual differences in the radiosensitivity of human skin. Eur. J. Cancer 28A: 1783-1791, 1992.
20. Turesson, I. and Thames, H.D. Repair capacity and kinetics of human skin during fractionated radiotherapy: erythema, desquamation, and telangiectasia after 3 and 5 years follow-up. Radiother. Oncol. 15: 169-188, 1989.